A detailed history of Sands Capital Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Sands Capital Management, LLC holds 2,334,901 shares of TXG stock, worth $38.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,334,901
Previous 3,383,141 30.98%
Holding current value
$38.1 Million
Previous $127 Million 64.23%
% of portfolio
0.14%
Previous 0.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$19.45 - $37.37 $20.4 Million - $39.2 Million
-1,048,240 Reduced 30.98%
2,334,901 $45.4 Million
Q1 2024

May 14, 2024

SELL
$36.08 - $54.3 $7.47 Million - $11.2 Million
-207,004 Reduced 5.77%
3,383,141 $127 Million
Q4 2023

Feb 13, 2024

SELL
$34.32 - $57.55 $13.6 Million - $22.8 Million
-395,325 Reduced 9.92%
3,590,145 $201 Million
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $5.51 Million - $8.49 Million
-134,799 Reduced 3.27%
3,985,470 $164 Million
Q2 2023

Aug 15, 2023

BUY
$50.96 - $58.72 $19.5 Million - $22.5 Million
382,501 Added 10.23%
4,120,269 $230 Million
Q1 2023

May 12, 2023

BUY
$35.33 - $55.79 $18.8 Million - $29.6 Million
530,985 Added 16.56%
3,737,768 $209 Million
Q4 2022

Feb 13, 2023

SELL
$24.4 - $41.3 $4.5 Million - $7.62 Million
-184,394 Reduced 5.44%
3,206,783 $117 Million
Q3 2022

Nov 09, 2022

SELL
$28.48 - $52.59 $3.86 Million - $7.14 Million
-135,701 Reduced 3.85%
3,391,177 $96.6 Million
Q2 2022

Aug 12, 2022

BUY
$36.95 - $82.41 $12 Million - $26.8 Million
325,484 Added 10.17%
3,526,878 $160 Million
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $85.6 Million - $224 Million
1,537,427 Added 92.4%
3,201,394 $244 Million
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $225 Million - $304 Million
1,663,967 New
1,663,967 $248 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.55B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.